What's new in surgical oncology: impact of immunology and tumour biology.
Heys
S D
SD
Department of Surgery, University of Aberdeen, Foresterhill, UK.
Eremin
O
O
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D009857:Oncogenes
D000970:Antineoplastic Agents; D006133:Growth Substances; D007155:Immunologic Factors